BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Omeros Corporation 

1420 Fifth Avenue
Suite 2675
Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856


SEARCH JOBS


Industry
Biotechnology






 Company News
Omeros Corporation (OMER) To Present At The 13th Annual Needham Healthcare Conference 4/7/2014 6:38:10 AM    More...
Omeros Corporation (OMER) Release: Investigational New Drug Application Cleared By FDA For OMS721 In Thrombotic Microangiopathies 4/3/2014 9:27:31 AM    More...
Omeros Corporation (OMER) Invited To Present On OMS824 Phase 2 Clinical Program At The Schizophrenia International Research Conference 4/1/2014 6:39:14 AM    More...
Omeros Corporation (OMER) To Present At Biocentury Future Leaders In The Biotech Industry Conference 3/21/2014 6:22:19 AM    More...
Omeros Corporation (OMER) Closes $40.25 Million Public Offering Of Common Stock 3/20/2014 6:57:38 AM    More...
Omeros Corporation (OMER) Prices $35 Million Public Offering Of Common Stock 3/14/2014 6:42:25 AM    More...
Omeros Corporation (OMER) Reports Fourth Quarter and Year-End 2013 Financial Results 3/14/2014 6:30:33 AM    More...
Omeros Corporation (OMER) Announces Positive OMS721 Data In Serum From Patients With aHUS 3/10/2014 8:17:36 AM    More...
Omeros Corporation (OMER) Touts Positive Data From Phase 2a Schizophrenia Drug Test 3/6/2014 6:51:30 AM    More...
Omeros Corporation (OMER) Closes $32 Million Debt Financing, Receiving $12.6 Million In New Funds 3/5/2014 6:56:39 AM    More...
12345678910...

//-->